Found: 24
Select item for more details and to access through your institution.
Stereotactical normalization with multiple templates representative of normal and Parkinson-typical reduction of striatal uptake improves the discriminative power of automatic semi-quantitative analysis in dopamine transporter SPECT.
- Published in:
- EJNMMI Physics, 2023, v. 10, n. 1, p. 1, doi. 10.1186/s40658-023-00544-9
- By:
- Publication type:
- Article
Impact of the size of the normal database on the performance of the specific binding ratio in dopamine transporter SPECT.
- Published in:
- EJNMMI Physics, 2020, v. 7, n. 1, p. 1, doi. 10.1186/s40658-020-00304-z
- By:
- Publication type:
- Article
Organ and tumor dosimetry including method simplification for [<sup>177</sup>Lu]Lu-PSMA-I&T for treatment of metastatic castration resistant prostate cancer.
- Published in:
- EJNMMI Physics, 2024, v. 11, n. 1, p. 1, doi. 10.1186/s40658-024-00668-6
- By:
- Publication type:
- Article
Whole-body biodistribution and radiation dosimetry of [<sup>18</sup>F]PR04.MZ: a new PET radiotracer for clinical management of patients with movement disorders.
- Published in:
- EJNMMI Research, 2022, v. 12, n. 1, p. 1, doi. 10.1186/s13550-021-00873-9
- By:
- Publication type:
- Article
Dopamine Transporter SPECT with 12-Minute Scan Duration Using Multiple-Pinhole Collimators.
- Published in:
- Journal of Nuclear Medicine, 2024, v. 65, n. 8, p. 1, doi. 10.2967/jnumed.123.266276
- By:
- Publication type:
- Article
Dopamine Transporter SPECT with 12-Minute Scan Duration Using Multiple-Pinhole Collimators.
- Published in:
- Journal of Nuclear Medicine, 2024, v. 65, n. 3, p. 446, doi. 10.2967/jnumed.123.266276
- By:
- Publication type:
- Article
Dopamine Transporter SPECT with 12-Minute Scan Duration Using Multiple-Pinhole Collimators.
- Published in:
- Journal of Nuclear Medicine, 2024, v. 65, n. 2, p. 1, doi. 10.2967/jnumed.123.266276
- By:
- Publication type:
- Article
Feasibility of <sup>99m</sup>Tc-MIP-1404 for SPECT/CT Imaging and Subsequent PSMA-Radioguided Surgery in Early Biochemically Recurrent Prostate Cancer: A Case Series of 9 Patients.
- Published in:
- Journal of Nuclear Medicine, 2023, v. 64, n. 1, p. 59, doi. 10.2967/jnumed.122.263892
- By:
- Publication type:
- Article
Feasibility of <sup>99m</sup> Tc-MIP-1404 for SPECT/CT imaging and subsequent PSMA-radioguided surgery in early biochemical recurrent prostate cancer: a case series of 9 patients.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 10, p. 1, doi. 10.2967/jnumed.122.263892
- By:
- Publication type:
- Article
Feasibility of <sup>99m</sup> Tc-MIP-1404 for SPECT/CT imaging and subsequent PSMA-radioguided surgery in early biochemical recurrent prostate cancer: a case series of 9 patients.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 9, p. 1, doi. 10.2967/jnumed.122.263892
- By:
- Publication type:
- Article
Evaluation of safety and dosimetry of 177Lu-DOTA-ZOL for therapy of bone metastases.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 12, p. 1, doi. 10.2967/jnumed.120.255851
- By:
- Publication type:
- Article
Evaluation of safety and dosimetry of <sup>177</sup>Lu-DOTA-ZOL for therapy of bone metastases.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 11, p. 1, doi. 10.2967/jnumed.120.255851
- By:
- Publication type:
- Article
Evaluation of safety and dosimetry of <sup>177</sup>Lu-DOTA-ZOL for therapy of bone metastases.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 10, p. 1, doi. 10.2967/jnumed.120.255851
- By:
- Publication type:
- Article
Evaluation of safety and dosimetry of <sup>177</sup>Lu-DOTA-ZOL for therapy of bone metastases.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 8, p. 1, doi. 10.2967/jnumed.120.255851
- By:
- Publication type:
- Article
Evaluation of safety and dosimetry of <sup>177</sup>Lu-DOTA-ZOL for therapy of bone metastases.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 7, p. 1, doi. 10.2967/jnumed.120.255851
- By:
- Publication type:
- Article
Evaluation of safety and dosimetry of <sup>177</sup>Lu-DOTA-ZOL for therapy of bone metastases.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 6, p. 1, doi. 10.2967/jnumed.120.255851
- By:
- Publication type:
- Article
Evaluation of safety and dosimetry of <sup>177</sup>Lu-DOTA-ZOL for therapy of bone metastases.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 5, p. 1, doi. 10.2967/jnumed.120.255851
- By:
- Publication type:
- Article
Evaluation of safety and dosimetry of <sup>177</sup>Lu-DOTA-ZOL for therapy of bone metastases.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 2, p. 1, doi. 10.2967/jnumed.120.255851
- By:
- Publication type:
- Article
Evaluation of safety and dosimetry of <sup>177</sup>Lu-DOTA-ZOL for therapy of bone metastases.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 3, p. 1, doi. 10.2967/jnumed.120.255851
- By:
- Publication type:
- Article
Evaluation of safety and dosimetry of <sup>177</sup>Lu-DOTA-ZOL for therapy of bone metastases.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 1, p. 1, doi. 10.2967/jnumed.120.255851
- By:
- Publication type:
- Article
<sup>68</sup>Ga-FAPI PET/CT: Biodistribution and Preliminary Dosimetry Estimate of 2 DOTA-Containing FAP-Targeting Agents in Patients with Various Cancers.
- Published in:
- Journal of Nuclear Medicine, 2019, v. 60, n. 3, p. 386, doi. 10.2967/jnumed.118.215913
- By:
- Publication type:
- Article
Effect of Peptide Dose on Radiation Dosimetry for Peptide Receptor Radionuclide Therapy with <sup>177</sup>Lu-DOTATOC: A Pilot Study.
- Published in:
- Indian Journal of Nuclear Medicine, 2021, v. 36, n. 4, p. 412, doi. 10.4103/ijnm.ijnm_15_21
- By:
- Publication type:
- Article
Biodistribution and dosimetry of a single dose of albumin-binding ligand [177Lu]Lu-PSMA-ALB-56 in patients with mCRPC.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2021, v. 48, n. 3, p. 893, doi. 10.1007/s00259-020-05022-3
- By:
- Publication type:
- Article
Development and dosimetry of <sup>203</sup>Pb/<sup>212</sup>Pb-labelled PSMA ligands: bringing "the lead" into PSMA-targeted alpha therapy?
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2019, v. 46, n. 5, p. 1081, doi. 10.1007/s00259-018-4220-z
- By:
- Publication type:
- Article